Cargando…
Which is the most effective strategy: early detection of coagulopathy with thromboelastometry or use of hemostatic factors or both?
Autores principales: | David, Jean-Stephane, Marchal, Virginie, Levrat, Albrice, Inaba, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218978/ https://www.ncbi.nlm.nih.gov/pubmed/21672283 http://dx.doi.org/10.1186/cc10224 |
Ejemplares similares
-
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
por: Katz, Daniel, et al.
Publicado: (2021) -
The role of thromboelastometry in the assessment and treatment of coagulopathy in liver transplant patients
por: Zamper, Raffael Pereira Cezar, et al.
Publicado: (2017) -
Hypothermic circulatory arrest induced coagulopathy: rotational thromboelastometry analysis
por: Ise, Hayato, et al.
Publicado: (2020) -
Thromboelastometry identifies coagulopathy associated with liver failure and disseminated intravascular coagulation caused by yellow fever, guiding specific hemostatic therapy: a case report
por: Crochemore, Tomaz, et al.
Publicado: (2020) -
Hemostatic resuscitation for acute traumatic coagulopathy
por: Scalea, Thomas M
Publicado: (2011)